Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Pulmonology
•
Diffuse Parenchymal Lung Disease
What factors do you consider when determining whether to perform a biopsy for the diagnosis of organizing pneumonia?
Related Questions
What criteria do you use to decide when to perform a BAL in hypersensitivity pneumonitis?
How do you approach a patient with sarcoidosis who cannot tolerate steroids and who is developing ILD?
Would you consider adding or switching to pirfenidone for a patient with progressing UIP (based on imaging and PFTs) who is currently on nintedanib?
Would you restart sirolimus for a decline in lung function or pneumothoraces in a pregnant patient with LAM?
In a patient with low titer +anti-SAE antibody and known ILD, but no other clinical features of dermatomyositis, how would you approach further testing or would you treat the patient as dermatomyositis associated ILD?
How do you approach patients with RA and severe bronchiectasis with associated findings of UIP?
How do you determine whether to add abatacept or rituximab to the treatment regimen in patients with mild RA-ILD on methotrexate?
Do you ever consider tapering off steroid-sparing agents in patients with stable non-IPF ILD?
Would you initiate antifibrotic therapy in a patient with CTD-ILD experiencing worsening symptoms and declining lung function, despite no clear evidence of fibrosis on CT scans?
What is your approach to evaluation and management of GERD in a patient with IPF?
